Research Article
The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial Hemorrhage
Table 2
General characters of patients with intracranial hemorrhage and the controls.
| | | Intracranial hemorrhage | Controls |
| | Age (yrs) | 55.05 (49.18–60.91) | 23.88 (14.70–33.06) | | M/F | 12/10 | 14/3 | | SBP (mmHg) | 175.5 (157.00–190.50) | 121.00 (100.50–133.00) | | DBP (mmHg) | 104.50 (94.50–111.25) | 70.00 (66.50–82.00) | | WBC (/L) | 11.94 (10.04–15.11) | 7.61 (5.93–11.04) | | RBC (/L) | 4.14 (3.80–4.48) | 4.51 (4.27–4.75) | | Hb (g/L) | 123.95 (115.29–132.63) | 128.06 (118.76–137.35) | | PLT (/L) | 193.50 (143.00–246.00) | 239.00 (169.00–313.00) | | LDH (U/L) | 247.14 (215.16–279.11) | 201.29 (166.33–236.26) | | AST (U/L) | 47.50 (30.00–88.00) | 26.00 (24.00–44.00) | | ALT (U/L) | 38.00 (19.00–90.00) | 21.00 (15.00–33.00) | | GGT (U/L) | 52.50 (23.00–88.00) | 17.00 (12.00–24.00) | | ALP (U/L) | 73.50 (56.00–87.00) | 90.00 (54.00–154.00) | | CHE (U/L) | 5.85 (4.90–6.81) | 7.16 (6.41–7.91) | | TP (g/L) | 65.71 (61.68–69.74) | 67.50 (64.19–70.81) | | ALB (g/L) | 36.36 (34.09–38.63) | 39.35 (37.90–40.81) | | Glu (mmol/L) | 3.93 (2.98–4.26) | 3.52 (3.31–4.16) | | Cl (mmol/L) | 121.17 (118.68–123.65) | 125.96 (122.75–129.17) | | ALB (g/L) | 0.93 (0.78–1.08) | 0.43 (0.30–0.55) | | WBC (/L) | 52.50 (28.00–233.50) | 11.00 (4.50–41.50) | | BBB ratio | 22.68 (17.46–32.79) | 9.69 (6.27–13.23) |
|
|
M: male; F: female; SBP: systolic blood pressure; DBP: diastolic blood pressure; CSF: cerebrospinal fluid; WBC: white blood cell; RBC: red blood cell; Hb: hemoglobin; PLT: platelet; LDH: L-lactate dehydrogenase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transpeptidase; ALP: alkaline phosphatase; CHE: cholinesterase; TP: total protein; Alb: albumin; GLB: globulin; Glu: glucose; Cl: chlorine; BBB ratio: Alb × 1000/Alb.
and when the intracranial hemorrhage group is compared with control.
|
